These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34812681)

  • 1. Causal simulation experiments: Lessons from bias amplification.
    Stokes T; Steele R; Shrier I
    Stat Methods Med Res; 2022 Jan; 31(1):3-46. PubMed ID: 34812681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian data fusion: Probabilistic sensitivity analysis for unmeasured confounding using informative priors based on secondary data.
    Comment L; Coull BA; Zigler C; Valeri L
    Biometrics; 2022 Jun; 78(2):730-741. PubMed ID: 33527348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causal Diagrams: Pitfalls and Tips.
    Suzuki E; Shinozaki T; Yamamoto E
    J Epidemiol; 2020 Apr; 30(4):153-162. PubMed ID: 32009103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causal inference accounting for unobserved confounding after outcome regression and doubly robust estimation.
    Genbäck M; de Luna X
    Biometrics; 2019 Jun; 75(2):506-515. PubMed ID: 30430543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis approaches to address treatment nonadherence in pragmatic trials with point-treatment settings: a simulation study.
    Hossain MB; Mosquera L; Karim ME
    BMC Med Res Methodol; 2022 Feb; 22(1):46. PubMed ID: 35172746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A flexible, interpretable framework for assessing sensitivity to unmeasured confounding.
    Dorie V; Harada M; Carnegie NB; Hill J
    Stat Med; 2016 Sep; 35(20):3453-70. PubMed ID: 27139250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measured and accounted-for confounding in pharmacoepidemiologic studies: Some thoughts for practitioners.
    Roy J; Mitra N
    Pharmacoepidemiol Drug Saf; 2021 Mar; 30(3):277-282. PubMed ID: 33372303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Causal directed acyclic graphs and the direction of unmeasured confounding bias.
    VanderWeele TJ; Hernán MA; Robins JM
    Epidemiology; 2008 Sep; 19(5):720-8. PubMed ID: 18633331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the impact of unmeasured confounders for credible and reliable real-world evidence.
    Zhang X; Stamey JD; Mathur MB
    Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1219-1227. PubMed ID: 32929830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian sensitivity analysis for unmeasured confounding in causal mediation analysis.
    McCandless LC; Somers JM
    Stat Methods Med Res; 2019 Feb; 28(2):515-531. PubMed ID: 28882092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causal Modeling to Mitigate Selection Bias and Unmeasured Confounding in Internet-Based Epidemiology of COVID-19: Model Development and Validation.
    Stockham N; Washington P; Chrisman B; Paskov K; Jung JY; Wall DP
    JMIR Public Health Surveill; 2022 Jul; 8(7):e31306. PubMed ID: 35605128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unifying instrumental variable and inverse probability weighting approaches for inference of causal treatment effect and unmeasured confounding in observational studies.
    Liu T; Hogan JW
    Stat Methods Med Res; 2021 Mar; 30(3):671-686. PubMed ID: 33213292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On a preference-based instrumental variable approach in reducing unmeasured confounding-by-indication.
    Li Y; Lee Y; Wolfe RA; Morgenstern H; Zhang J; Port FK; Robinson BM
    Stat Med; 2015 Mar; 34(7):1150-68. PubMed ID: 25546152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Illustrating How to Simulate Data From Directed Acyclic Graphs to Understand Epidemiologic Concepts.
    Fox MP; Nianogo R; Rudolph JE; Howe CJ
    Am J Epidemiol; 2022 Jun; 191(7):1300-1306. PubMed ID: 35259232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity analysis of G-estimators to invalid instrumental variables.
    Vancak V; Sjölander A
    Stat Med; 2023 Oct; 42(23):4257-4281. PubMed ID: 37497859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Summarizing causal differences in survival curves in the presence of unmeasured confounding.
    Martínez-Camblor P; MacKenzie TA; Staiger DO; Goodney PP; O'Malley AJ
    Int J Biostat; 2020 Sep; 17(2):223-240. PubMed ID: 32946418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Instrumental variable estimation of the causal hazard ratio.
    Wang L; Tchetgen Tchetgen E; Martinussen T; Vansteelandt S
    Biometrics; 2023 Jun; 79(2):539-550. PubMed ID: 36377509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DAG With Omitted Objects Displayed (DAGWOOD): a framework for revealing causal assumptions in DAGs.
    Haber NA; Wood ME; Wieten S; Breskin A
    Ann Epidemiol; 2022 Apr; 68():64-71. PubMed ID: 35124197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Instrumental variable estimation of truncated local average treatment effects.
    Choi BY
    PLoS One; 2021; 16(4):e0249642. PubMed ID: 33819276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causal graphical views of fixed effects and random effects models.
    Kim Y; Steiner PM
    Br J Math Stat Psychol; 2021 May; 74(2):165-183. PubMed ID: 33063334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.